Dallah Healthcare Co (SAU:4004) EBIT: ﷼641 Mil (TTM As of Mar. 2026)


SAU:4004 Dallah Healthcare Co SAU:4004
92 GF Score
Price ﷼112.00
GF Value ﷼204.73
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Dallah Healthcare Co EBIT?

Dallah Healthcare Co SAU:4004 92 EBIT is ﷼641 Mil as of Mar. 2026. GuruFocus rates SAU:4004 with a GF Score™ of 92/100 and a GF Value™ of ﷼204.73 (Possible Value Trap). The stock has 8 warning signs investors should review.

Dallah Healthcare Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ﷼131 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼641 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Dallah Healthcare Co's annualized ROC % for the quarter that ended in Mar. 2026 was 4.97%. Dallah Healthcare Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Dallah Healthcare Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.22%.


Dallah Healthcare Co  (SAU:4004) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Dallah Healthcare Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=438.888 * ( 1 - 3.07% )/( (8461.329 + 8643.643)/ 2 )
=425.4141384/8552.486
=4.97 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9135.304 - 463.41 - ( 210.565 - max(0, 1570.623 - 1944.451+210.565))
=8461.329

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9312.097 - 481.037 - ( 187.417 - max(0, 1679.79 - 2022.428+187.417))
=8643.643

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Dallah Healthcare Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=525.016/( ( (4651.923 + max(977.379, 0)) + (4741.62 + max(1051.026, 0)) )/ 2 )
=525.016/( ( 5629.302 + 5792.646 )/ 2 )
=525.016/5710.974
=9.19 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1196.422 + 359.678 + 126.763) - (463.41 + 0 + 242.074)
=977.379

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1262.908 + 373.285 + 178.771) - (481.037 + 0 + 282.901)
=1051.026

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Dallah Healthcare Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=641.386/15203.438
=4.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dallah Healthcare Co EBIT Related Terms


Dallah Healthcare Co EBIT Historical Data

* Premium members only.

The historical data trend for Dallah Healthcare Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dallah Healthcare Co EBIT Chart

Dallah Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 333.67 399.63 504.46 610.09 697.12

Dallah Healthcare Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 186.99 167.30 167.69 175.14 131.25

SAU:4004 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Dallah Healthcare Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dallah Healthcare Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dallah Healthcare Co's EV-to-EBIT falls into.


SAU:4004
92GF Score
Dallah Healthcare Co SAU:4004
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dallah Healthcare Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼641 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ﷼641 Mil mean?
Dallah Healthcare Co (SAU:4004) has a EBIT of ﷼641 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Dallah Healthcare Co.
Is Dallah Healthcare Co's EBIT too high?
Dallah Healthcare Co's current EBIT is ﷼641 Mil. Overall, Dallah Healthcare Co has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's EBIT compare to HCA and THC?
Dallah Healthcare Co's EBIT of ﷼641 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Dallah Healthcare Co. Dallah Healthcare Co's current EBIT is ﷼641 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼204.73, compared to a current price of ﷼112.00 — trading 45.3% below its estimated fair value. The current EBIT is ﷼641 Mil. Dallah Healthcare Co's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current EBIT is ﷼641 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?

Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued. The current stock price of ﷼112.00 is trading 45.3% below its estimated GF Value™ of ﷼204.73. GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.

Key valuation signals for SAU:4004:

  • EBIT: ﷼641 Mil
  • GF Value™: ﷼204.73 vs. price of ﷼112.00 (45.3% below fair value)
  • GF Score™: 92/100 with 8 warning signs

No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dallah Healthcare Co Business Description

Address 1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
92GF Score

Get the complete analysis for SAU:4004

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼112.00
Price
﷼204.73
GF Value